✦ LIBER ✦

Safety, tolerability, and preliminary efficacy of SAM-531, a 5HT-6 antagonist, in subjects with mild-to-moderate Alzheimer's disease: Results from a phase 2a study

✍ Scribed by Claudine Brisard; Beth Safirstein; Kevin Booth; Lisa Hua; Yves Brault; Sangeeta Raje; Steven Leventer

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

O3-04-06: Efficacy and tolerability of S

✍ Marina Zvartau-Hind; Gareth Maher-Edwards; Jackie Hunter; Michael Gold; Gillian 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 68 KB

P4-341: Efficacy and tolerability of SB-

✍ Maher-Edwards, Gareth; Dixon, Ruth; Hunter, Jackie; Gold, Michael; Hopton, Gilli 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 181 KB

48-week efficacy and tolerability of tre

✍ Maher-Edwards, Gareth; Ascher, John; Watson, Carolyn; Zvartau-Hind, Marina; Dono 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 54 KB

Safety and tolerability of rosiglitazone

✍ Marina Zvartau-Hind; Claire Alderton; Sally Ritchie; Ann Saunders; Michael Iriza 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 169 KB

O2-05-08: A phase III study of the effic

✍ Paul Aisen; Serge Gauthier; Richard Briand; Daniel Saumier; Graziella Soulban; D 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 47 KB

A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONT

✍ Cummings, Jeffrey; Cho, William; Ward, Michael; Friesenhahn, Michel; Brunstein, 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 51 KB